Navigation Links
Roxane Laboratories, Inc. Announces the Launch of Acarbose Tablets
Date:5/7/2008

COLUMBUS, Ohio, May 7 /PRNewswire/ -- Roxane Laboratories, Inc. announced today the approval of their Abbreviated New Drug Application for Acarbose Tablets, 25mg, 50mg, and 100mg. The product is available in bottles of 100 tablets for all strengths as well as Unit Dose Blisters for the 50mg strength and is available for immediate shipment to wholesalers and pharmacies nationwide.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' Acarbose Tablets are AB rated to PRECOSE(R) (acarbose). Annual sales of PRECOSE(R) (acarbose) Tablets are approximately $35 Million(1).

Full prescribing information for Acarbose Tablets is available on the Roxane Laboratories website at http://www.Roxane.com or upon request by calling Roxane Laboratories Technical Product Information at 1.800.962.8364.

About Roxane Laboratories, Inc.

Roxane Laboratories is located in Columbus, OH in a modern 500,000 square foot manufacturing and laboratory facility. The facility spans 70 acres and currently employs over 1,000 people. Currently, Roxane Laboratories markets over 75 medications in nearly 250 package sizes, focusing on an expanding line of Multisource pharmaceutical products including: bulk and unit-dose liquids and solids; coated, sustained-release and controlled-release tablets; nasal sprays, cytotoxics and CII narcotics.

Roxane Laboratories, Inc. is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.

About Boehringer Ingelheim

Boehringer Ingelheim Corporation based in Ridgefield, CT, is the US headquarters to seven subsidiaries and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companie
'/>"/>

SOURCE Roxane Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg
2. Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
3. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
4. Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
5. Forest Laboratories, Inc. Reports Fiscal Year 2008 Fourth Quarter Reported EPS of $0.55 Including $0.35 Per Share Charge for Licensing Payment
6. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Fourth Quarter Earnings
7. Stiefel Laboratories, Inc. Appoints New President
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
10. Forest Laboratories, Inc. and Merz Pharma GmbH & Co. KgaA File Lawsuits Against Several Companies for Patent Infringement
11. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Free hearing aids will be given by Estes Aud... Austin, TX (PRWEB) December...m ), a professional hearing healthcare provider de...ired and their families, announced today the begin...giveaway. Each year, Estes Audiology donates two ...
(Date:12/1/2009)... Anthony M. Marlon, MD was elected to the Ste...dquo;) Board of Directors at the Company’s N... (PRWEB) December 1, 2009 -- Anthony M. Marlon...es , Inc. (“Stemedica”) Board of Direc...eting. Roger J. Howe, PhD, Executive Chairman for ...
(Date:12/1/2009)...T BEACH, Calif., Dec. 1 To date, h...rs will reimburse them for the $20 cost of the dis...nder, for surgery. ,, Anesthesiologists have no... to avoid postop dementia from routine anesthesia ...heard the ,avoid over-medication, message from the...
(Date:12/1/2009)...TLE, Dec. 1 Cell Ther...ment,s presentation at the 21st Annual Piper Jaffr...t 11:00 a.m. Eastern Time will be webcast live at ...on will take place in Holmes 1 at the New York Pal...fter the presentation. , , P...
(Date:12/1/2009)...resented today at the annual meeting of the Radiol...at MRI is a highly accurate means of identifying p...d increasingly common condition that is the leadin...iving birth. , "Due to the increase in cesarean...on the uterine wall, coupled with women giving bir...
Breaking Medicine News(10 mins):Health News:Estes Audiology Offers the Gift of Hearing to Celebrate the Holiday Season 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 2Health News:Prominent Health Care Executive Joins Stemedica Board Of Directors 3Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2
...en removed with immediate effect from the shops in...in them. The FSA based its recommendations// for t...Food Standards Agency traced benzene during a surv...times recommended UK levels. Two companies have al...
... in Los Angeles Superior Court accuses sunscreen m...ancer by making false claims on their products.// ...r lawsuits, has named manufacturers like Copperton...putting consumers at risk of getting the disease o...
.... health regulators, gave their nod to the first n...ion in heart transplant patients.// The drug, A...to prevent rejection of liver and kidney transplan...nts in the U.S. each year will now have a new opti...
...cial India’s population stabilization solely rests...desh//, which has the highest fertility rates. ...ihar and Uttar Pradesh take an immediate lead in c...sh, fail to bring down the fertility growth rate, ...
...ed a further six months of patent extension by the...dication//, Provigil. Cephlaon had complied...t entailed the provision of clinical studies data ...c firms, and under this settlement, each of the fo...
...issed increased risk of heart attack associated wi...at his views are 'out of the mainstream' as it is ...mpany, Merck and Co. Thomas Cona and John Mc...filed against the controversial Vioxx, on grounds ...
Other Medicine News:Health News:Doctor Grilled In Court For False Report About Vioxx Health Risk 2
(Date:11/30/2009)... , SCOTTSDALE, Ariz., Nov. 30 /PRNewswire-F...ding provider of radiology solutions to radiology ... has implemented a redesigned Quality Assurance (Q...NightHawk,s radiologists and customers and to deli...be providing an overview of the new QA program in ...
(Date:11/30/2009)..., MT. LAUREL, N.J., Nov. 30 /PRNewswire-First...ng provider of technology-enabled clinical documen...week at the Radiological Society of North America ... for Radiology, the product leverages SpeechQ(TM)...nition application used by thousands of radiologis...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Diabe..., http://www.reportlinker.com/p0164347/Diabetes-..., Diabetes Diagnosis market is driven by a stea... diabetes, both in the developed and developing pa...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 2Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 3Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 4Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 5Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 6Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 7Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 8Reportlinker Adds Diabetes Diagnostics - A Global Market Perspective 9First human gets new antibody aimed at rabies virus 10189 1First human gets new antibody aimed at rabies virus 10189 2First human gets new antibody aimed at rabies virus 10189 3Lack of Social Interaction Affects Health Outcomes of Breast Cancer Stress from loneliness leads to increased tumor growth Decrease breast cancer r 58565 1Lack of Social Interaction Affects Health Outcomes of Breast Cancer Stress from loneliness leads to increased tumor growth Decrease breast cancer r 58565 2Lack of Social Interaction Affects Health Outcomes of Breast Cancer Stress from loneliness leads to increased tumor growth Decrease breast cancer r 58565 3Lack of Social Interaction Affects Health Outcomes of Breast Cancer Stress from loneliness leads to increased tumor growth Decrease breast cancer r 58565 4In Key Opinion Leader Management Quantity Does Not Equal Quality in Evaluating a Scientist 26apos 3Bs Real Importance 14302 1In Key Opinion Leader Management Quantity Does Not Equal Quality in Evaluating a Scientist 26apos 3Bs Real Importance 14302 2In Key Opinion Leader Management Quantity Does Not Equal Quality in Evaluating a Scientist 26apos 3Bs Real Importance 14302 3
...ciple Studies -, GAITHERSBURG, Md., April 3, 2008...ed that it has signed an agreement,with Merck & Co...studies,evaluating the use of the Iomai needle-fre...to negotiate an exclusive license. These,preclinic...ing an,undisclosed Merck vaccine. Iomai recently a...
...ounced a,cash injection from Midroc New Technology...opment and Ostersjostiftelsen. The capital will be...rst candidate drug. The majority,will be used to i... Atopic,Dermatitis (AD), for which the company has... the company,s R & D pipeline., "We are pleased t...
Other Medicine Technology:Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 2Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch 3DermaGen AB Receives Over 1 Million Euros From a New Share Issue 2DermaGen AB Receives Over 1 Million Euros From a New Share Issue 3
McKenty Periosteal Elevator
Roger Elevator
Woodson Elevator
Henner Elevator
Medicine Products: